The research team of Prof. Wanliang Lv has studied a recombinant PD1 liposome loaded nintedanib for the treatment of pulmonary fibrosis

Journal of Chinese Pharmaceutical Sciences ›› 2025, Vol. 34 ›› Issue (11): 1062-1062.

The research team of Prof. Wanliang Lv has studied a recombinant PD1 liposome loaded nintedanib for the treatment of pulmonary fibrosis

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

Received:2025-11-03 Revised:2025-11-03 Accepted:2025-11-03 Online:2025-12-02 Published:2025-12-02

Abstract

Supporting:

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The research team of Prof. Wanliang Lv has studied a recombinant PD1 liposome loaded nintedanib for the treatment of pulmonary fibrosis[J]. Journal of Chinese Pharmaceutical Sciences, 2025, 34(11): 1062-1062.

The research team of Prof. Wanliang Lv has studied a recombinant PD1 liposome loaded nintedanib for the treatment of pulmonary fibrosis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Recommended Articles

Metrics

Comments